Molecular biology of human papillomavirus infection and cervical cancer
The DOI matches its Crossref record; 172 of the 179 references it cites were found in a registry or an index.
Abstract
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types have been identified so far, with a subset of these being classified as high risk. High-risk HPV DNA is found in almost all cervical cancers (>99.7%), with HPV16 being the most prevalent type in both low-grade disease and cervical neoplasia. Productive infection by high-risk HPV types is manifest as cervical flat warts or condyloma that shed infectious virions from their surface. Viral genomes are maintained as episomes in the basal layer, with viral gene expression being tightly controlled as the infected cells move towards the epithelial surface. The pattern of viral gene expression in low-grade cervical lesions resembles that seen in productive warts caused by other HPV types. High-grade neoplasia represents an abortive infection in which viral gene expression becomes deregulated, and the normal life cycle of the virus cannot be completed. Most cervical cancers arise within the cervical transformation zone at the squamous/columnar junction, and it has been suggested that this is a site where productive infection may be inefficiently supported. The high-risk E6 and E7 proteins drive cell proliferation through their association with PDZ domain proteins and Rb (retinoblastoma), and contribute to neoplastic progression, whereas E6-mediated p53 degradation prevents the normal repair of chance mutations in the cellular genome. Cancers usually arise in individuals who fail to resolve their infection and who retain oncogene expression for years or decades. In most individuals, immune regression eventually leads to clearance of the virus, or to its maintenance in a latent or asymptomatic state in the basal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“human papillomavirus (HPV) is thought to initiate cervical carcinoma and squamous cell carcinoma of the head and neck in part by inactivating RB through expression of the E7 oncoprotein21,22”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
In the citing paper
“in HPV-induced cervical cancers, the virus initiates cancer in dividing cells in the basal layer of the epithelium, preventing their normal cell cycle exit and maturation21.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Research works printed but not linked: 2
- Villiers de, 2001, Taxonomic classification of papillomaviruses, Papillomavirus Rep., 12, 57
- Sorathia, 2004, The E4 protein of HPV16 Interacts with E2 and regulates the trans-activation and replication functions of E2, 318
Cited by
Items 401–500 of 1,000
Human papillomavirus and human telomerase RNA component gene in cervical cancer progression
Liu, Y., Fan, P., Yang, Y., Xu, C., Huang, Y., Li, D., Qing, Q., Sun, C., & Zhou, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-52195-5 · Cited by 21
Chen, H., Xia, B., Zheng, T., & Lou, G. (2019) · The International Journal of Biological Markers · doi:10.1177/1724600819888771 · Cited by 21
Uddin, M. N., Kouzi, S. A., & Hussain, M. D. (2015) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3rs3v · Cited by 22
“Among these five types, two of them, Alpha and Beta, contain about 90% of currently characterized HPVs [5-7].”
Koczorowska, M. M., Kwaśniewska, A., & Goździcka‐Józefiak, A. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2010.174 · Cited by 21
“…isoform in cervical cancer was found to correspond to simultaneous expression of HPV viral E6 and E7 proteins during the late stages of neoplasia (1). hpV viral early proteins are involved in a variety of intracellular processes, including splicing. it has previously been demonstrated by Bell et…”
Filho, S. M. A., Golub, J. E., Nuovo, G. J., da Cunha, C. B., Levi, J. E., Villa, L. L., de Andrade, C. V., Russomano, F. B., Tristão, A., PIRES, A. R. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057810 · Cited by 21
“The high risk HPV types are able to actuate the complex pathways that ultimately leads to an invasive cancer, in part, due to the ability of E6 and E7 viral oncoproteins to drive cells into S-phase [5].”
BackgroundHusain, E. A., Prowse, D. M., Ktori, E., Shaikh, T., Yaqoob, M. M., Junaid, I., & Baithun, S. I. (2009) · Pathology · doi:10.1080/00313020902756303 · Cited by 21
“66, 68, low risk types 6, 11, 40, 42, 43, 44, 54, 74 and unclassified types 53 and 70.(11,12)”
Chang, Y.-F., Yan, G.-J., Liu, G., Hong, Y., Chen, H.-L., Jiang, S., Zhong, Y., Xiyang, Y., & Hu, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.718781 · Cited by 21
HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
Zhou, K., Yuzhakov, O., Behloul, N., Wang, D., Bhagat, L., Chu, D., Zhang, X., Cheng, X., Fan, L., Huang, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1213285 · Cited by 26
“9 kb long nucleotide belt, segmented into three regions: the early (E) region encoding for viral proteins regulating the virus life cycle and the cellular functions of the infected epithelial cells, the late (L) region encoding for the structural proteins of the viral icosahedral capsid that mediates cell entry, and t…”
BackgroundHPV-assoziierte Plattenepithelkarzinogenese
Assmann, G., & Sotlar, K. (2011) · Der Pathologe · doi:10.1007/s00292-011-1442-2 · Cited by 23
Lee, S. J., Lee, A.-W., Kang, C., Park, J. S., Park, D.-C., Ki, E. Y., Lee, K., Yoon, J.-H., Hur, S. Y., & Kim, T. J. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.5585 · Cited by 20
“We postulated that these conditions could be observed during (1) viral entry or persistence before viral synthesis in the HPV life cycle and (2) HPV DNA integration in the human genome [24].”
BackgroundMale Circumcision and Serologically Determined Human Papillomavirus Infection in a Birth Cohort
Dickson, N. P., Ryding, J., van Roode, T., Paul, C., Herbison, P., Dillner, J., & Skegg, D. C. G. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0353 · Cited by 20
“By contrast, most women with detectable HPV DNA become HPV DNA negative within a year and it is not clear whether this reflects a biological clearance of the virus or an inability of HPV DNA tests to detect continued presence of a latent infection (22).”
BackgroundThe role of the NORE1A tumor suppressor in Oncogene-Induced Senescence
Barnoud, T., Schmidt, M., Donninger, H., & Clark, G. J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.030 · Cited by 27
“Further studies have identified alterations in the Rb gene or inactivation of the Rb protein in a variety of human cancers, and it is now widely accepted that the inactivation of Rb may be one of the most frequent events in cancer (58-60).”
Chaberek, K., Mrowiec, M., Kaczmarek, M., & Dutsch‐Wicherek, M. (2022) · Diagnostics · doi:10.3390/diagnostics12081906 · Cited by 20
“The HPV replication cycle involves the infection of basal keratinocytes in an abrased epithelium [29,30].”
BackgroundLuo, X., Hong, X., Xiong, X., Zeng, L., & Lim, C. E. D. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e318234fd8a · Cited by 20
Tropé, A., Jonassen, C. M., Sjøborg, K., Nygård, M., Dahl, F. A., Alfsen, G. C., & Lie, A. K. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.07.032 · Cited by 20
“expression of the E6/E7 oncogenes is necessary for malignant transformation and maintenance of the neoplastic state [16,17].”
BackgroundVibrational Spectroscopy: Disease Diagnostics and Beyond
Byrne, H. J., Ostrowska, K. M., Nawaz, H., Dorney, J., Meade, A. D., Bonnier, F., & Lyng, F. M. (2013) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-94-007-7832-0_13 · Cited by 24
Chen, Z., Liu, K., Li, L., Chen, Y., & Du, S. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.06.006 · Cited by 20
“As a tumor suppressor, down-regulated RB1 drives tumorigenesis in many malignant tumors, including gastric cancer[21], liver cancer [22], small-cell lung carcinoma [23], and cervical carcinoma [24].”
BackgroundDoorslaer, K. V., DeSalle, R., Einstein, M. H., & Burk, R. D. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004980 · Cited by 20
“PDZ containing proteins regulate multiple biological processes including differentiation and the maintenance of cellular polarity [17,18,19,20,21].”
BackgroundDigital RNA Sequencing of Human Epidermal Keratinocytes Carrying Human Papillomavirus Type 16 E7
Hua, C., Zhu, J., Zhang, B., Sun, S., Song, Y., van der Veen, S., & Cheng, H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00819 · Cited by 20
“HPV displays a high affinity for mucosal and cutaneous epithelia and only infects basal proliferating keratinocytes (Doorbar, 2006).”
BackgroundObservations on the expression of human papillomavirus major capsid protein in HeLa cells
Xiao, C.-Y., Fu, B.-B., Li, Z., Mushtaq, G., Kamal, M. A., Li, J., Tang, G.-C., & Xiao, S. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0206-0 · Cited by 24
“start, thus there is no L1 expression [11–16].”
InfluentialConesa‐Zamora, P., Torres‐Moreno, D., Isaac, M. A., & Pérez‐Guillermo, M. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.06.011 · Cited by 19
Etiological role of human papillomavirus infection in the development of penile cancer
Sakamoto, J., Shigehara, K., Nakashima, K., Kawaguchi, S., Nakashima, T., Shimamura, M., Yasuda, M., Kato, T., Hasegawa, T., Kobori, Y., et al. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.11.003 · Cited by 19
Cervical Ectopy and the Acquisition of Human Papillomavirus in Adolescents and Young Women
Hwang, L. Y., Lieberman, P., Ma, Y., Farhat, S., & Moscicki, A. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182571f47 · Cited by 28
Boulabiar, M., Boubaker, S., Fãvre, M., & Demeret, C. (2011) · Journal of General Virology · doi:10.1099/vir.0.032466-0 · Cited by 19
“High levels of viral DNA replication, synthesis of capsid proteins and virus particles assembly are confined to suprabasal and terminally differentiated keratinocytes (Doorbar, 2006).”
BackgroundZhang, H., Li, W., Wang, G., Su, Y., Zhang, C., Chen, X., Xu, Y., & Li, K. (2011) · Virology Journal · doi:10.1186/1743-422x-8-298 · Cited by 19
“It has been confirmed that the last 4 amino acids of the NS1 C-terminal are the PDZ binding motif, which modulates the virulence in different strains of viruses [1,24].”
BackgroundHuman Papillomavirus 16 Infection Induces VAP-Dependent Endosomal Tubulation
Siddiqa, A., Massimi, P., Pim, D., Broniarczyk, J. K., & Banks, L. (2018) · Journal of Virology · doi:10.1128/jvi.01514-17 · Cited by 19
“becomes deregulated, this can ultimately result in the development of cancer (5).”
BackgroundSaccardi, C., Gizzo, S., Noventa, M., Anis, O., Gangi, S. D., Patrelli, T. S., D’Antona, D., & Nardelli, G. B. (2013) · Reproductive Sciences · doi:10.1177/1933719113492214 · Cited by 18
Prigge, E., Urban, K., Stiegler, S., Müller, M., Kloor, M., Mai, S., Ottstadt, M., Lohr, F., Wenz, F. K., Wagner, S., et al. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.08.001 · Cited by 19
“In HPV-driven tumors, overexpression of the HPV oncogenes E6 and E7 induces malignant transformation by interaction with critical cellular pathways [6].”
BackgroundShafei, M. N., Zainon, N., Zulkifli, N. F., & Ibrahim, M. I. (2014) · Procedia - Social and Behavioral Sciences · doi:10.1016/j.sbspro.2014.01.640 · Cited by 18
Yip, K. Y.-L., Utz, L., Sitwell, S., Hu, X. S., Sidhu, S. S., Turk, B. E., Gerstein, M., & Kim, P. M. (2011) · BMC Biology · doi:10.1186/1741-7007-9-53 · Cited by 18
“Some viruses co-opt host PRDs via mimicry, emphasizing their relevance to human diseases [3-5].”
BackgroundSquarzanti, D. F., Sorrentino, R., Landini, M. M., Chiesa, A. D., Pinato, S., Rocchio, F., Mattii, M., Penengo, L., & Azzimonti, B. (2018) · Virology Journal · doi:10.1186/s12985-018-1086-4 · Cited by 22
Genomic alterations caused by HPV integration in a cohort of Chinese endocervical adenocarcinomas
Li, W., Lei, W., Chao, X., Song, X., Bi, Y., Wu, H., Wu, M. P., & Li, L. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-020-00283-4 · Cited by 20
Multiplex Visualized Closed-Tube PCR with Hamming Distance 2 Code for 15 HPV Subtype Typing
Weng, J., Sheng, N., Wang, R., Liang, S., Wang, C., Bai, X., Zhou, G., Zou, B., & Song, Q. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00035 · Cited by 18
CCND1 G870A polymorphism and cervical cancer risk: a case–control study and meta-analysis
Ni, J., Wang, M., Wang, M., Fu, S., Zhou, D., Zhang, Z., & Han, S. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0904-x · Cited by 18
“Epidemiological and laboratory-based studies have demonstrated that one of the 15 high-risk, or oncogenic, human papillomavirus (HPV) types is a necessary, but not sufficient, cause of cervical cancer (Zur Hausen 2002; Roden and Wu 2006; Doorbar 2006 ).”
BackgroundSong, X., Chang-chun, L., Hong, Y., & Zhu, X.-C. (2015) · Bangladesh Journal of Pharmacology · doi:10.3329/bjp.v10i4.23709 · Cited by 18
“Human papillomavirus (HPV) infection has been found to have a distinct link with cervical cancer (Doorbar, 2006).”
BackgroundHui, C., Bai, H., Liu, J., Lu, X., Wang, S., Zhang, Z., Jin, M., Wang, Y., & Liu, Y. (2021) · Diagnostic Pathology · doi:10.1186/s13000-021-01072-9 · Cited by 21
van de Laar, R. L. O., Hofhuis, W., Duijnhoven, R. G., Bekkers, R. L. M., Smedts, H. P. M., Boer, G. M. N.-D., van Beekhuizen, H. J., Oei, A. L. M., Bouman, A., van de Swaluw, J. M. G., et al. (2025) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/j.lanogw.2025.100007 · Cited by 17
McInnis, C. M., Bhatia, S., Vijaykumar, B., Tian, Q., Sun, Y., Leistritz-Edwards, D., Quinn, C. T., Uppaluri, R., Egloff, A. M., Srinivasan, L., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006721 · Cited by 18
Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022
Zheng, L., Zheng, L., Chen, S., Liu, W., Qi, J., & Li, K. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29360 · Cited by 17
Spatio-temporal dynamics and aetiology of proliferative leg skin lesions in wild British finches
Lawson, B., Robinson, R. A., Fernández, J. R.-R., John, S. K., Benítez, L., Tolf, C., Risely, K., Toms, M. P., Cunningham, A. A., & Williams, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-32255-y · Cited by 17
Landaverde, L., Wong, W. S., Hernandez, G., Fan, A., & Klapperich, C. M. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02702-9 · Cited by 17
RNA-based gene targeting therapies for human papillomavirus driven cancers
Salinas-Montalvo, A. M., Supramaniam, A., McMillan, N. A. J., & Idris, A. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.005 · Cited by 20
High-Risk Human Papillomavirus Infection in Lung Cancer: Mechanisms and Perspectives
Osorio, J. C., Candia-Escobar, F., Corvalán, A. H., Calaf, G. M., & Aguayo, F. (2022) · Biology · doi:10.3390/biology11121691 · Cited by 21
Pathogenesis of Infection by Human Papillomavirus
Brendle, S. A., Bywaters, S. M., & Christensen, N. D. (2014) · Current problems in dermatology · doi:10.1159/000355963 · Cited by 17
Ochi, H., Kondo, K., Matsumoto, K., Oki, A., Yasugi, T., Furuta, R., Hirai, Y., Yoshikawa, H., & Kanda, T. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00197-08 · Cited by 17
“In the infected cells, the viral DNA is maintained as episomes, which start to be transcribed and replicate with the onset of terminal cell differentiation (5).”
BackgroundCheung, J. L. K., Cheung, T., Tang, J. W.-T., & Chan, P. K. S. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01785-07 · Cited by 20
“The HPV genome can exist in two physical states: it can either be a circular episomal form or integrated into the human genome (10).”
BackgroundInduction of focal epithelial hyperplasia in tongue of young bk6-E6/E7 HPV16 transgenic mice
Ocadiz‐Delgado, R., Marroquin-Chavira, A., Hernandez-Mote, R., Valencia, C., Manjarrez-Zavala, M. E., Covarrubias, L., & Gariglio, P. (2009) · Transgenic Research · doi:10.1007/s11248-009-9243-6 · Cited by 17
“also bind and stimulate the degradation of several cellular targets that contain PDZ motifs, such as hDlg and hScrib, which are thought to be tumor suppressor proteins involved in the regulation of cell growth and attachment (Doorbar 2006; Du et al. 2005; Matsumoto et al. 2006; Takizawa et al. 2006; Zeitler et al. 200…”
BackgroundRyan, F. (2009) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2009.090289 · Cited by 17
Jones, S., Hibbitts, S. J., Hurt, C. N., Bryant, D. J., Fiander, A., Powell, N. G., & Tristram, A. J. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0040 · Cited by 17
Márquez-Gutiérrez, M. A., Benítez‐Hess, M. L., DiPaolo, J. A., & Álvarez-Salas, L. M. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.04.011 · Cited by 17
Bilyk, O., Pande, N. T., Pejovic, T. B., & Buchinska, L. G. (2014) · PubMed · Cited by 22
Li, C., Xiaona, W., Zhiling, Y., Zhang, Y., Shuyuan, L., Yang, J., Hong, C., Shi, L., Hongying, Y., & Yufeng, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.21235 · Cited by 16
“The reason for the discrepancies could be the onset of cervical cancer is a multistep process that means progression of cervical cancer is from normal tissue to invasive cervical cancer through a series increasing grades of squamous intraepithelial lesions [52].”
BackgroundThe role of transforming growth factor β in cervical carcinogenesis
Trugilo, K. P., Cebinelli, G. C. M., Castilha, E. P., da Silva, M. R., Berti, F. C. B., & de Oliveira, K. B. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.10.006 · Cited by 17
Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis
Knoff, J. S., Yang, B. K., Hung, C., & Wu, T. ‐. (2013) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-013-0068-1 · Cited by 16
“HPV is comprised of an icosahedral capsid enclosing an approximately 8-kilobase-pair genome that encodes early proteins, including the oncoproteins E6 and E7, and late proteins that form the capsid of the virion (for review, see [15]).”
BackgroundPosition paper—HPV and the primary prevention of cancer; improving vaccine uptake by paediatricians
Ramet, J., Esso, D. V., & Mészner, Z. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1265-9 · Cited by 20
“Those that infect the genitalia can cause cancers of the cervix, vulva and vagina in women, cancers of the penis in men and anal cancers and anogenital warts in both sexes [27, 54].”
BackgroundNatural Products Mediated Targeting of Virally Infected Cancer
Fatima, I., Kanwal, S., & Mahmood, T. (2019) · Dose-Response · doi:10.1177/1559325818813227 · Cited by 16
Zhao, Y., Huang, J., Liu, T., He, S., Shang, C., Guo, L., Du, Q., & Yao, S. (2018) · PubMed · Cited by 16
Sitarz, K., Czamara, K., Białecka, J., Klimek, M., Szostek, S., & Kaczor, A. (2021) · Cancers · doi:10.3390/cancers13091997 · Cited by 18
“In turn, the E7 protein binds to the active domains of the Rb protein, which prevents Rb from interacting with the transcription factor E2F, leading to the stimulation of cell division [10].”
BackgroundScreening and risk factors for anal cancer precursors in men infected with HIV in Taiwan
Cheng, S., Chu, F., Wang, C., & Hsueh, Y. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23825 · Cited by 16
“Other studies have previously reported on the significance of high-grade squamous intraepithelial lesions [Goldstone et al., 2009; de Pokomandy et al., 2011; Wentzensen et al., 2012], a meaningful precursor of anal cancer that should be treated [Doorbar, 2006].”
BackgroundLin, C.-C., Tsai, C.-C., Lee, J., Fang, C.-H., Chang, K.-S., Wong, K., Lin, C.-T., & Qiu, J.-T. T. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.106 · Cited by 16
HPV L1 Capsid Protein Detection and Progression of Anal Squamous Neoplasia
Hernandez, J. M., Elahi, A. H., Siegel, E. M., Coppola, D., Riggs, B. M., & Shibata, D. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpr5vd6nsqrwbn · Cited by 16
Prophylactic human papillomavirus vaccines: past, present and future
Anderson, L. A. (2011) · Pathology · doi:10.1097/pat.0b013e32834d7bd8 · Cited by 16
Mandal, P., Bhattacharjee, B., Ghosh, D. D., Mondal, N. R., Chowdhury, R. R., Roy, S. S., & Sengupta, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065647 · Cited by 17
“However, high grade cervical neoplasia appears to be characterized by deregulated viral gene expression and abortive life cycle of the virus [11].”
BackgroundCladel, N. M., Budgeon, L. R., Hu, J., Balogh, K. K., & Christensen, N. D. (2013) · Virology · doi:10.1016/j.virol.2013.01.005 · Cited by 16
“For a review of the molecular biology of papillomaviruses see (Doorbar, 2006).”
BackgroundMuñoz, M., Camargo, M., León, S. C. S., Sánchez, R., Pineda-Peña, A.-C., Prados, A. P., Patarroyo, M. E., & Patarroyo, M. A. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01302-13 · Cited by 16
“In contrast, spontaneous regression rates are considerably reduced for immunocompromised women in occasional cases involving HIV coinfection (7), leading to a decline in the number of CD4 T lymphocytes (8).”
BackgroundSchafer, K., Neumann, J., Waterboer, T., & Rösl, F. (2010) · Journal of General Virology · doi:10.1099/vir.0.023515-0 · Cited by 16
“The E2 protein is expressed early in the lower epidermal layers, promoting virus replication, whereby further skin differentiation and virus maturation is ensured (Doorbar, 2006).”
BackgroundFalco, F. D., Cutarelli, A., Gentile, I., Cerino, P., Uleri, V., Cătoi, A. F., & Roperto, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658762 · Cited by 16
“Real time RT-PCR of mRNA of these IKKs showed significant reduced levels of mRNA of all three kinases in urothelial cells infected by BPVs compared to uninfected, heathy urothelial cells (Figures 6A–”
BackgroundInfluentialRoos, P., Orlando, P. A., Fagerstrom, R. M., & Pepper, J. W. (2015) · Scientific Reports · doi:10.1038/srep08645 · Cited by 16
Natural product derived immune-regulatory agents
Talmadge, J. E. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.02.025 · Cited by 17
Merkel Cell Polyomavirus: A New DNA Virus Associated with Human Cancer
MacDonald, M., & You, J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5765-6_4 · Cited by 16
“Like papillomavirus-induced cancers, MCPyV-associated MCC tumors typically carry the viral genome integrated into the host genome [1, 29, 30].”
BackgroundDrakopoulou, E., Anagnou, N. P., & Pappa, K. I. (2022) · Cancers · doi:10.3390/cancers14133238 · Cited by 18
Mendonça, F., Teles, A. M., Nascimento, M. D. D. S. B., dos Santos, A. P. S. D. A., Lopes, F. F., de Paiva, A. C., Brito, H. O., & da Costa, R. M. G. (2022) · In Vivo · doi:10.21873/invivo.12990 · Cited by 16
Coupé, V. M. H., González-Barreiro, L., Gutiérrez‐Berzal, J., Melián-Bóveda, A. L., López-Rodríguez, O., Alba-Domínguez, J., & Alba-Losada, J. (2011) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200330 · Cited by 15
“The E1 and E2 proteins are replication factors that are considered essential for the maintenance of the viral genome and copy number in the basal cells.(2) The E2 protein plays a fundamental role in the virus life cycle and may function as a transcriptional repressor of the HPV-16 viral oncogenes E6 and E7.”
BackgroundInfluentialSehr, P. A., Pawlita, M., & Lewis, J. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107301246 · Cited by 15
“Prophylactic vaccines based on virus-like particles have been successfully tested in clinical trials and have been commercially available since 2006.3 These vaccines target the major high-risk types HPV16 and HPV18, which account for approximately 70% of cervical cancer, so that even under optimal conditions, the need…”
BackgroundInfluentialŞahbaz, A., & Erol, O. Ö. (2014) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.22230 · Cited by 19
Viral warts (Human Papilloma Virus) as a potential risk for breast cancer among younger females
Atique, S., Hsieh, C.-H., Hsiao, R.-T., Iqbal, U., Nguyen, P., Islam, M. M., Li, Y., Hsu, C., Chuang, T., & Syed-Abdul, S. (2017) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2017.03.024 · Cited by 15
Patumraj, S., Niruthisard, Bhattarakosol, Mahasiripanth, T., & Hokputsa (2012) · Cancer Management and Research · doi:10.2147/cmar.s33596 · Cited by 15
“The high-risk types of HPV (HR-HPV) are, HPV-16, and HPV-18, which account for approximately 50% and 20% of all cervical cancers, respectively.(5,6) HR-HPV contains two critical oncogenes, E6 and E7, which are involved in the carcinogenesis of host cells.”
BackgroundRecent advances in molecular gynaecological pathology
Herrington, C. S. (2009) · Histopathology · doi:10.1111/j.1365-2559.2008.03216.x · Cited by 14
“The precise function of the E5 protein is also unclear.(5) The Address for correspondence: C S Herrington, Bute Medical School, University of St Andrews, St Andrews, UK.”
BackgroundEvaluation of interleukin 8 and interleukin 10 cytokines in liquid based cervical cytology samples
Osiagwu, D. D., Azenabor, A., Osijirin, A. A., Awopetu, P. I., & Oyegbami, F. R. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.32.148.16314 · Cited by 14
“These mostly arise within the transformation zone at the squamo-columnar junction of the cervix [5, 6].”
BackgroundAvcı, G. A., & Bozdayı, G. (2013) · Kafkas Journal of Medical Sciences · doi:10.5505/kjms.2013.52724 · Cited by 14
Evans, M. F., Adamson, C. S.-C., Schned, L. M., John, T. L. S., Leiman, G., Ashikaga, T., & Cooper, K. (2010) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181c1482c · Cited by 14
“However, it has been reported that approximately 90% of HPV infections may be cleared within a 2-year period(19) and some of the HPV detected in the NILM specimens may be latent HPV detectable because of the increased detection sensitivity of the nested PCR approach.(8,20) The apparent high prevalence of HPV is consis…”
BackgroundHPV in HIV-Infected Women: Implications for Primary Prevention
McKenzie, N. D., Kobetz, E. N., Ganjei‐Azar, P., Rosa-Cunha, I., Potter, J. E., Morishita, A., Lucci, J. A., Guettouche, T., Hnatyszyn, J. H., & Koru‐Sengul, T. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00179 · Cited by 14
“The alpha species of HPV are those subgroups of the virus that infect the genito-anal epithelium (19).”
BackgroundExpressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix
Ramirez, N. J., Guerra, F., Camporeale, G., Quintana, S., Díaz, L., Cuneo, N. A., Hidalgo, J. V., Tatti, S., Alonso, L. G., Borkosky, S. S., et al. (2015) · Biotechnic & Histochemistry · doi:10.3109/10520295.2015.1047794 · Cited by 14
“The involvement of E7 in cell cycle regulation is reinforced by the activity of the protein, E6, which binds to p53, a key factor in pro-apoptotic control (zur Hausen 2002, Doorbar 2006, Duensing et al. 2004, Sherman et al. 1997, Funk et al. 1997, Thomas and Banks 1998).”
BackgroundTherapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix
Ragonnaud, E., Andersson, A.-M. C., Mariya, S., Pedersen, A. G., Burk, R. D., Folgori, A., Colloca, S., Cortese, R., Nicosia, A., Pamungkas, J., et al. (2017) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000153 · Cited by 15
Ren, C., Yang, L., Zhu, Y., Bai, Y., & Zhang, X. (2017) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_56_17 · Cited by 16
Tsakogiannis, D., Moschonas, G. D., Bella, E., Kyriakopoulou, Z., Amoutzias, G. D., Dimitriou, T. G., Kottaridi, C., & Markoulatos, P. (2017) · Journal of Medical Virology · doi:10.1002/jmv.24996 · Cited by 15
Ali, S. M. A., Mirza, Y., Ahmad, Z., Zahid, N., & Enam, S. A. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.10.018 · Cited by 15
P16 expression in relation to human papillomavirus in liquid-based cervical smears
Samama, B., Schaeffer, C., & Boehm, N. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.043 · Cited by 14
Hall, M. T., Hyatt, A., Smith, M. A., Torode, J., Costa, T., Nguyen, D., Balshaw, T., Grogan, P. B., Sweeny, K., Auste, C., et al. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101423 · Cited by 14
Przybylski, M., Pruski, D., Millert-Kalińska, S., Krzyżaniak, M., de Mezer, M., Frydrychowicz, M., Jach, R., & Żurawski, J. (2023) · Biomedicines · doi:10.3390/biomedicines11010225 · Cited by 14
“, it is a critical determinant for effective viral replication and potentially crucial in virus–host immune interaction [6].”
BackgroundKreijne, J. E., Goetgebuer, R., Erler, N. S., de Boer, N. K. H., Siebers, A. G., Dijkstra, G. D. H., van Kemenade, F. J., Hoentjen, F., Oldenburg, B., Jong, A. E. V. D. M., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17555 · Cited by 13
Impact of human papillomavirus types on uterine cervical neoplasia
Taguchi, A., Yoshimoto, D., Kusakabe, M., Baba, S., Kawata, A., Miyamoto, Y., Mori, M., Sone, K., Hirota, Y., & Osuga, Y. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15995 · Cited by 13
“8,9 E1 encodes a virus-specific DNA helicase which is necessary for viral replication.”
Development of human papillomavirus and its detection methods (Review)
Jin, J. J., Li, S., Huang, H., Li, J., Lyu, Y., Ran, Y., Chang, H., & Zhao, X. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12671 · Cited by 13
“The current understanding of the receptor for HPV invasion into cells remains unclear, since HPV not only binds to normal squamous epithelial cells but also to various other cell types (53,54).”
BackgroundRasizadeh, R., Aghbash, P. S., Mokhtarzadeh, A., Poortahmasebi, V., Oskouee, M. A., Nahand, J. S., Amini, M., Mahdavi, S. Z. B., Yari, A. H., & Baghi, H. B. (2024) · Gene · doi:10.1016/j.gene.2024.148904 · Cited by 13
Emerging and re-emerging infectious disease in otorhinolaryngology
SCASSO, F., FERRARI, G., Vincentiis, G. C. D., Arosio, A. D., Bottero, S., CARRETTI, M., CIARDO, A., Cocuzza, S. G., COLOMBO, A., Conti, B., et al. (2018) · Acta Otorhinolaryngologica Italica · doi:10.14639/0392-100x-suppl.1-38-2018 · Cited by 17
Zhang, Z., & Zhu, Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512494 · Cited by 14
“The expression of viral oncoproteins, including E6 and E7, encoded by HPV genetic material, contributes to epigenetic dysregulation, influencing the initiation and spread of cervical cancer [106].”
BackgroundMartró, E., Valencia, M. J., Tarrats, A., Castellà, E., Llatjós, M., Franquesa, S., Matas, L., & Ausina, V. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.09.019 · Cited by 13
Biesaga, B., Szostek, S., Klimek, M., Jakubowicz, J., & Wysocka, J. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2012.0033 · Cited by 13
“Integration causes disruption of viral E2 gene — a negative regulator of the E6 and E7 genes promoter [4].”
BackgroundMonroy, A., Gómez-Lim, M. Á., Weiss‐Steider, B., la Rosa, G. P.-D., Hernández‐Montes, J., Pérez-Saldaña, K., Tapia-Guerrero, Y. S., Toledo-Guzmán, M. E., Santiago‐Osorio, E., Sánchez-Peña, H. I., et al. (2011) · Virology Journal · doi:10.1186/1743-422x-8-59 · Cited by 15
“Notably, HPV-16 accounts for 50% to 60% of all HPV DNA-positive cervical cancers [3].”
Backgroundp16 Positive Histologically Bland Squamous Metaplasia of the Cervix
Goyal, A., Ellenson, L. H., & Pirog, E. C. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001364 · Cited by 13
Metadata
- Authors
- Doorbar, J.
- Affiliations
- National Institute for Medical Research (GB)
- Corresponding author
- Doorbar, John
- ORCID
- Doorbar, John
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2006-04-11
- Volume
- 110
- Issue
- 5
- Pages
- 525-541
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2052489835
- Cited by
- 1,072
- References
- 179
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 34 · 2023: 41 · 2022: 51 · 2021: 43 · 2020: 52 · 2019: 45 · 2018: 60 · 2017: 55 · 2016: 58 · 2015: 64 · 2014: 73 · 2013: 98 · 2012: 83
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human papillomavirus, cervical cancer, HPV16, high-risk HPV, viral gene expression, cervical neoplasia, cervical transformation zone, E6 oncoprotein, E7 oncoprotein, retinoblastoma protein, p53 degradation, PDZ domain proteins, abortive infection, viral latency, immune clearance
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Precancerous Conditions, Virus Latency, Disease Progression, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.